The use of dexmedetomidine in oral and maxillofacial operative surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003865

Enrollment

Unknown

Registered

2013-11-02

Start date

2014-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cleft lip and palate

Interventions

A:dexmedetomidine

B:placebo

Eligibility

Sex/Gender

All

Age

No minimum to 3 Years

Inclusion criteria

Inclusion criteria: The infant who experienced the cleft lip and palate reconstructive surgery, aged from 3moths to 3years.

Exclusion criteria

Exclusion criteria: bradycardia, influenza, coagulopathy or major systemic illness

Design outcomes

Primary

Measure	Time frame
Heart rate;blood pressure;	—

Countries

China

Contacts

Public ContactPENG WEI

Hospital of stomatology of Wuhan University

squirrel_3211@163.com+86 15327193757

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 4, 2026